S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
MarketBeat Week in Review – 12/4 - 12/8
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
MarketBeat Week in Review – 12/4 - 12/8
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
MarketBeat Week in Review – 12/4 - 12/8
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
MarketBeat Week in Review – 12/4 - 12/8
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod

Clover Health Investments Stock Price, News & Analysis (NASDAQ:CLOV)

$0.95
+0.01 (+1.06%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.93
$0.97
50-Day Range
$0.88
$1.13
52-Week Range
$0.71
$1.63
Volume
5.48 million shs
Average Volume
5.62 million shs
Market Capitalization
$463.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.92

Clover Health Investments MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
101.7% Upside
$1.92 Price Target
Short Interest
Bearish
5.21% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.18mentions of Clover Health Investments in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.53) to ($0.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

804th out of 942 stocks

Hospital & Medical Service Plans Industry

10th out of 11 stocks


CLOV stock logo

About Clover Health Investments Stock (NASDAQ:CLOV)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.

CLOV Stock Price History

CLOV Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
CLOV Clover Health Investments, Corp.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Q3 2023 Clover Health Investments Corp Earnings Call
What's Going On With Clover Health Stock Tuesday?
Clover Health Promotes Karen Soares to General Counsel
What's Going On With Clover Health Investments Stock?
See More Headlines
Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/09/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
656
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.92
High Stock Price Target
$3.00
Low Stock Price Target
$1.25
Potential Upside/Downside
+101.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-338,840,000.00
Pretax Margin
-9.35%

Debt

Sales & Book Value

Annual Sales
$3.48 billion
Book Value
$0.73 per share

Miscellaneous

Free Float
381,240,000
Market Cap
$463.36 million
Optionable
Not Optionable
Beta
1.91
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Vivek  GaripalliMr. Vivek Garipalli (Age 44)
    Co-Founder & Executive Chairman
  • Mr. Andrew Toy (Age 44)
    Co-Founder, CEO & Director
    Comp: $1.01M
  • Mr. Scott J. Leffler (Age 48)
    Chief Financial Officer
    Comp: $420.19k
  • Mr. Brady Priest J.D. (Age 46)
    Chief Executive Officer of Home Care
    Comp: $587.36k
  • Mr. Conrad Wai (Age 42)
    Chief Technology Officer
  • Mr. Derrick L. Nueman
    Head of Investor Relations & Corporate strategy
  • Ms. Wendy Richey
    Chief Compliance Officer
  • Ms. Karen Soares
    General Counsel, Senior VP & Corporate Secretary
  • Ms. Rachel Fish
    Chief People Officer
  • Ms. Jamie L. Reynoso (Age 53)
    Chief Executive Officer of Medicare Advantage
    Comp: $461.74k














CLOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Clover Health Investments stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View CLOV analyst ratings
or view top-rated stocks.

What is Clover Health Investments' stock price target for 2024?

3 brokers have issued 12-month target prices for Clover Health Investments' stock. Their CLOV share price targets range from $1.25 to $3.00. On average, they predict the company's stock price to reach $1.92 in the next twelve months. This suggests a possible upside of 101.7% from the stock's current price.
View analysts price targets for CLOV
or view top-rated stocks among Wall Street analysts.

How have CLOV shares performed in 2023?

Clover Health Investments' stock was trading at $0.9295 at the beginning of the year. Since then, CLOV shares have increased by 2.2% and is now trading at $0.9502.
View the best growth stocks for 2023 here
.

Are investors shorting Clover Health Investments?

Clover Health Investments saw a increase in short interest in November. As of November 15th, there was short interest totaling 25,430,000 shares, an increase of 5.3% from the October 31st total of 24,150,000 shares. Based on an average daily volume of 4,110,000 shares, the short-interest ratio is currently 6.2 days.
View Clover Health Investments' Short Interest
.

When is Clover Health Investments' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our CLOV earnings forecast
.

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) issued its earnings results on Monday, November, 6th. The company reported ($0.09) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The company earned $482.07 million during the quarter, compared to analysts' expectations of $491.30 million. Clover Health Investments had a negative trailing twelve-month return on equity of 75.65% and a negative net margin of 9.37%.

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include PNC Financial Services Group Inc. (1.05%), Charles Schwab Investment Management Inc. (0.38%), Qube Research & Technologies Ltd (0.28%), Connor Clark & Lunn Investment Management Ltd. (0.17%), Northern Trust Corp (0.16%) and AQR Capital Management LLC (0.16%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro.
View institutional ownership trends
.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CLOV) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -